Successful endovascular treatment of abdominal aortic rupture secondary to bacillus Calmette-Guérin vaccine.
J Vasc Surg Cases Innov Tech
washington; everett; BCG vaccine; EVAR treatment; Infected graft; Mycotic pseudoaneurysm; Prophylaxis
Bacillus Calmette-Guérin (BCG) vaccine has been successfully used to treat bladder cancer. However, sporadic cases of mycotic arterial aneurysms have been reported. These patients typically develop a Mycobacterium bovis infection of an existing aneurysm or graft. In the present report, we have described the case of a patient with a ruptured nonaneurysmal abdominal aorta years after intravesicular BCG therapy. Emergent aortic endograft repair was successful. After subsequent evaluation confirmed M. bovis infection, the patient was treated with a prolonged course of antimycobacterial therapy. Vascular surgeons should maintain suspicion for atypical aortic ruptures in patients with exposure to intravesicular BCG therapy.
Liechty, Andrew E; Pacifico, Albert; and Brant-Zawadzki, Peter, "Successful endovascular treatment of abdominal aortic rupture secondary to bacillus Calmette-Guérin vaccine." (2022). Articles, Abstracts, and Reports. 5712.